Skip to content

A comparative study of diclofenac skin patch against oral diclofenac for pain control after root canal treatment

The efficacy of transdermal and oral diclofenac for post-endodontic pain control: A Randomised controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/03/008207
Enrollment
32
Registered
2017-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients diagnosed with symptomatic irreversible pulpitis in relation to first or second premolar tooth of either jaw

Interventions

Intervention1: Transdermal Diclofenac patch: Patients will receive post-treatment transdermal diclofenac patch (100 mg) once a day for two days. These patients will also be given Paracetamol (500 mg)

Sponsors

Faculty of Dental Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy persons, 18-65 years of age reporting to the Department of Conservative Dentistry and Endodontics, Faculty of Dental Sciences, Bangalore with pain in posterior tooth. 2. First or second premolar tooth of either jaw diagnosed as symptomatic irreversible pulpitis. 3. Teeth that could be treated endodontically in one visit 4. Intraoral periapical radiograph showing intact lamina dura and no periapical radiolucency and absence of anatomical obstacles like calcifications in the canals, and no anticipated procedural difficulties. 4. Patients giving no recent history of any antibiotic or analgesic taken.

Exclusion criteria

Exclusion criteria: 1. Known hypersensitivity to diclofenac. 2. Pregnancy or lactation. 3. Patients with history of asthma or allergy to anti-inflammatory drugs. 4. Patients with active peptic ulceration within the last six months 5. Patients undergoing treatment with other NSAIDs or any other analgesics or corticosteroids during the trial period

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of transdermal diclofenac patch for post-endodontic pain management.Timepoint: After two days, the effectiveness of transdermal diclofenac patch will be assessed.

Secondary

MeasureTime frame
To compare the effect of transdermal diclofenac patch against oral diclofenac for post-endodontic pain managementTimepoint: After two days, the effect of transdermal diclofenac patch against oral diclofenac for post-endodontic pain management will be compared.

Countries

India

Contacts

Public ContactDr Shivani Mangal

Ramaiah University of Applied Sciences

sylviamathew@yahoo.co.in9844330333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026